Acetonitrile Market By Grade (Pharmaceutical Grade, Industrial Grade, HPLC Grade, LC-MS and UHPLC Grade, Other High-Purity and Specialty Grades); By Application (Pharmaceutical Manufacturing, Analytical and Laboratory Testing, Chemical Synthesis and Extraction, Agrochemicals, Electronics and Semiconductors, Battery Manufacturing, Other Applications); By End User (Pharmaceutical and Biotechnology Companies, Chemical Manufacturers, Research and Analytical Laboratories, Agrochemical Producers, Semiconductor and Electronics Companies, Battery Manufacturers); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Acetonitrile Market: Pharmaceutical Purity Requirements and Co-Product Supply Economics Shape Expansion

Pharmaceutical and Analytical Demand Is Moving the Market Toward Higher-Value Grades

The Global Acetonitrile Market was valued at USD 0.43 billion in 2025 and is projected to reach USD 0.65 billion by 2032, expanding at a CAGR of 6.1% during 2026–2032, according to Strategic Market Research.

 

Demand for acetonitrile is increasing due to its wide range of applications across several high-growth industries. In pharmaceuticals, it is widely used in drug production and purification because it dissolves well and supports efficient processing of active ingredients and medicines. In laboratories, particularly in HPLC applications, it serves as an essential solvent for accurate testing and impurity detection in pharmaceutical, food, and chemical analysis. The agrochemical industry also contributes to rising demand, as acetonitrile is used in the production of pesticides and herbicides for agriculture. Additionally, it finds application in the battery sector, where it is used in manufacturing processes for advanced batteries, including those designed for electric vehicles.

 

Pharmaceutical Manufacturing Creates Demand but Also Imposes Strict Solvent Controls

Acetonitrile is widely used in pharmaceutical manufacturing as a reaction solvent, extraction medium, and purification aid due to its strong polarity and compatibility with organic compounds. INEOS highlights its use in producing key medicines such as insulin and vaccines, reflecting its role in regulated drug manufacturing. In market terms, pharmaceuticals account for 36.0% of global demand (USD 154.8 million in 2025), while pharmaceutical-grade material represents 42.0% of total revenue (USD 180.6 million), showing strong demand for high-purity supply.

Growth is supported by ongoing drug development activity. The US FDA approved 46 novel drugs in 2025, and industry practice shows that each new drug typically requires hundreds to thousands of HPLC tests, each using small but repeated volumes of acetonitrile. This creates steady demand in analytical laboratories even when per-test usage is low.

Regulation also shapes usage. Under ICH Q3C(R9), acetonitrile is a Class 2 solvent with a permitted daily exposure of 4.1 mg/day and a limit of 410 ppm in finished drugs. These strict thresholds require sensitive testing methods and tight process control, often at low-ppm detection levels.

 

HPLC and LC-MS Workflows Support Recurring, Specification-Driven Consumption

High-performance liquid chromatography (HPLC) grade accounted for 23.0% of the market in 2025, worth about USD 98.9 million. Analytical and laboratory use also held a 23.0% share, while research labs made up 17.0% of demand (USD 73.1 million). Together, these segments are driven by routine use in quality control, pharmaceutical testing, environmental analysis, food safety, forensics, and LC-MS workflows.

HPLC and LC-MS applications are estimated to represent roughly 28% of total acetonitrile consumption due to frequent repeat testing in regulated industries. Demand is steady because laboratories rely on high-purity solvent for consistent instrument performance. For example, LC-MS grade acetonitrile typically requires ≥99.8% purity with ultra-low metal content (often below 0.1 ppm) to avoid signal interference.

Although pharmaceutical-grade solvent dominates overall demand, HPLC-grade remains important because it is sold in high-value, small-pack formats and requires strict purification and documentation. Growth in LC-MS and biomolecule testing is expected to support demand, with industry estimates suggesting 7% annual growth in advanced analytical applications, although newer low-solvent instruments may slightly reduce per-test consumption.

 

Industrial, Agrochemical and Electronics Uses Broaden the Revenue Base

Industrial grade accounted for 35.0% of the 2025 market, or USD 150.5 million, with chemical manufacturers such as INEOS, BASF, and Sinopec contributing 25.0% of end-user revenue (USD 107.5 million). These manufacturers use acetonitrile mainly for synthesis, extraction, and intermediate production where high analytical purity is not always required.

Agrochemicals made up 12.0% of application revenue (USD 51.6 million), supported by use in pesticides and crop-protection intermediates, with demand from major agrochemical players such as Bayer, Syngenta and Corteva through contract manufacturing and intermediate supply chains.

Electronics represented 7.0% of applications (USD 30.1 million), while semiconductor and electronics firms such as TSMC, Samsung Electronics, and Intel accounted for 10.0% of end-user revenue (USD 43.0 million), with demand driven by high-purity requirements in contamination-sensitive wafer fabrication, lithography, and precision cleaning processes.

Asia remains a key hub, with SEMI reporting that leading manufacturers such as TSMC, Samsung Electronics, SK Hynix, and SMIC drive semiconductor-equipment spending across China, Taiwan, and South Korea, reinforcing strong regional demand for high-purity solvents.

 

Co-Product Production Creates a Structural Supply Constraint

The key risk in the acetonitrile market is the mismatch between where demand comes from and how supply is produced. Around 85% of global acetonitrile is recovered as a co-product of acrylonitrile manufacturing, so availability depends more on polymer and plastics production (like ABS and acrylic fibres) than on solvent demand itself. Since these polymers account for roughly 75% of acrylonitrile use, even small shifts in plastics demand can tighten or loosen acetonitrile supply, regardless of steady pharmaceutical and lab consumption.

INEOS highlights this structure through its integrated nitriles operations in the US (Green Lake and Lima) and Europe (Köln), where acetonitrile is recovered in small single-digit percentage yields alongside acrylonitrile. On the demand side, risk is managed through long-term contracts and backup suppliers. About 80% of pharmaceutical and analytical buyers use multi-year agreements, while 55% qualify secondary suppliers.

Recycling is emerging but still limited. A 2024 study showed acetonitrile recovery rates of 80% in oligonucleotide manufacturing, but real-world use is constrained by purification and regulatory validation needs. Overall, solvent recovery may reduce virgin demand by about 15% at plant level, while increasing demand for purification and validation systems.

 

Asia-Pacific Leads Through Pharmaceutical Production and Electronics Manufacturing

Asia-Pacific led the market in 2025 with 40.0% share (USD 172.0 million), driven by strong pharmaceutical, agrochemical, electronics, and laboratory activity, including companies such as Sun Pharma, Dr. Reddy’s Laboratories, UPL Ltd, Sumitomo Chemical, Samsung Electronics, and TSMC. India is a key contributor, with pharmaceutical exports reaching USD 30.5 billion in FY2024–25, reflecting large-scale solvent and analytical chemical use. The region is also expanding capacity, with 38 government-backed API and intermediate projects commissioned by December 2025, adding about 56,800 tonnes of annual output across related inputs.

North America held 25.0% (USD 107.5 million), supported by pharmaceutical innovation and biotech research (e.g., Pfizer, Moderna, Amgen) and strong demand for HPLC and LC-MS grade solvents used in analytical and quality-control laboratories.

Europe accounted for 23.0% (USD 98.9 million), backed by pharmaceutical R&D spending of about EUR 55 billion in 2024, with demand driven by companies such as Roche, Novartis, and Bayer, alongside ongoing requirements for high-purity solvents and supply security concerns.

Latin America and the Middle East & Africa made up 7.0% and 5.0% respectively, with demand mainly driven by imports for pharmaceutical, laboratory testing and agrochemical applications, supported by end users such as EMS and Eurofarma in Brazil, Aspen Pharmacare in South Africa, and regional agrochemical formulators and analytical laboratories, with growth tied to gradual industrial and research expansion.

 

Competitive Landscape and Key Companies

INEOS Nitriles — “Europe’s New Acetonitrile Capacity Push Signals Strategic Shift Toward Bio-Attributed and Pharma-Grade Supply Security”
INEOS Nitriles holds a prominent upstream position and identifies itself as the world’s largest producer of acrylonitrile and acetonitrile. The company manufactures and markets acetonitrile globally through its integrated nitriles network, including facilities in Green Lake and Lima in the United States and Köln in Germany. Its competitive advantage comes from access to acrylonitrile production, purification capability and established bulk logistics. INEOS has also introduced ISCC Plus-certified, bio-attributed acetonitrile and announced plans for a 15-kilotonne-per-year acetonitrile unit at Köln to serve European pharmaceutical, agrochemical and bioscience customers.

 

Asahi Kasei — “Battery Innovation Push Opens New Frontier for Acetonitrile Beyond Traditional Solvent Markets”
Asahi Kasei participates through its essential chemicals business and lists acetonitrile within its chemical portfolio. The company is also expanding the potential use of acetonitrile in advanced batteries. Its Acetolyte technology uses an acetonitrile-containing electrolyte designed to improve ionic conductivity and high-power performance. EAS Batteries began selling an ultra-high-power cell incorporating this electrolyte in June 2026, moving the technology beyond laboratory development into an initial commercial application. This development could create a specialized demand category separate from conventional pharmaceutical and chromatography consumption.

 

Thermo Fisher Scientific — “Analytical Powerhouse Strengthens Grip on High-Purity Solvent Supply Chain for Pharma QC and Research Labs”
In the analytical-solvent segment, Thermo Fisher Scientific supplies acetonitrile across anhydrous, ACS, HPLC, LC-MS and UHPLC-MS grades. Its broad product range and laboratory distribution network support recurring purchases by pharmaceutical quality-control laboratories, universities, testing facilities and biotechnology companies. Competitive differentiation is based on assay level, ultraviolet transparency, trace-metal limits, water content and availability in controlled small-pack formats.

 

Merck — “Ultra-High Purity Standards Drive Merck’s Positioning in Chromatography-Grade Acetonitrile Market”
Merck, through its Sigma-Aldrich and Supelco brands, provides HPLC, HPLC-GC, UHPLC-MS and spectroscopy-grade acetonitrile. Some products specify purity levels of at least 99.9%, reflecting the tighter requirements of gradient chromatography, ultraviolet analysis and mass-spectrometry workflows. The company competes through application-specific grades, global laboratory distribution and supporting analytical documentation.

 

Avantor — “Application-Specific Solvent Strategy Strengthens Avantor’s Role in Regulated Laboratory and Testing Ecosystems”
Avantor supplies acetonitrile through brands including J.T.Baker, BAKER ANALYZED, Rankem and HiPerSolv CHROMANORM. Its portfolio covers HPLC gradient analysis, spectrophotometry, pesticide-residue testing and preparative separation. Product-level certificates, management-of-change information and controlled packaging are particularly relevant to laboratories that must maintain validated methods.

 

Acetonitrile Market Report Coverage Table

Report Attribute	Details
Forecast Period	2026 – 2032
Market Size Value in 2025	USD 0.43 Billion
Revenue Forecast in 2032	USD 0.65 Billion
Overall Growth Rate	CAGR of 6.1% (2026 – 2032)
Base Year for Estimation	2025
Historical Data	2019 – 2024
Unit	USD Million, CAGR (2026 – 2032)
Segmentation	By Grade, By Application, By End User, By Geography
By Grade	Pharmaceutical Grade, Industrial Grade, HPLC Grade, LC-MS and UHPLC Grade, Other High-Purity and Specialty Grades
By Application	Pharmaceutical Manufacturing, Analytical and Laboratory Testing, Chemical Synthesis and Extraction, Agrochemicals, Electronics and Semiconductors, Battery Manufacturing, Other Applications
By End User	Pharmaceutical and Biotechnology Companies, Chemical Manufacturers, Research and Analytical Laboratories, Agrochemical Producers, Semiconductor and Electronics Companies, Battery Manufacturers
By Region	North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Country Scope	U.S., Canada, UK, Germany, France, Italy, China, Japan, South Korea, India, Brazil, Mexico, Saudi Arabia, UAE, South Africa
Market Drivers	Rising pharmaceutical demand for high-purity processing solvents; recurring HPLC and LC-MS solvent consumption in regulated laboratories; expanding agrochemical, semiconductor and advanced-battery applications; growing need for documented and specification-controlled solvent grades
Customization Option	Available upon request